Nebenwirkungen · Bimervax
BIMERVAX XFG.1.1 emulsion for injection BIMERVAX XFG.1.1 emulsion for injection in pre-filled syringe COVID-19 Vaccine (recombinant, adjuvanted) · Abschnitt 4.8 · PDF-Seite 49–50
HOS-151314 · Präparat HOS-100493
Gastrointestinal Diarrhoea Odynophagia disorders Vomiting Abdominal painb Nausea Skin and Pruritus Urticaria subcutaneous Cold sweats tissue disorders Rash Erythema Musculoskeletal Myalgia Arthralgia and connective tissue disorders General disorders Injection Injection site Asthenia Injection site and site pain swelling Chills bruising administration Fatigue Injection site Malaise Injection site site conditions erythema Injection site hypersensitivity Injection site pruritus induration Pyrexia Axillary pain a This term also included events reported as lymphadenitis b This term also included events reported as upper and lower abdominal pain c Based on a single event during clinical trials 49 Paediatric population
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T13:15:05Z · SHA-256 9021815ee653b04aa62b8ee1b9ae8cc9cdf72bb8edc2998f5a88fe9d974331b9 · Passage 06b4eec77bb8912725cd0e703e696a613b651666913e9d5fcf311a712b317836 · Zeichen 5016–6510 im Abschnitt